Partner Therapeutics is dedicated to delivering high-quality products and partnering with clinical teams to drive improved outcomes for patients and their families.

Medicines listed on this website are the main products that Partner Therapeutics provides globally. These medicines may not be available in all countries or regions, and may be available under different brand names and trademarks, for different indications and patient populations, in different dosages, and in different strengths.

Please visit our local country or region websites for local product information.

Patient Support (US Residents Only)

Partner Therapeutics offers the PTxAssist patient services program designed to support patients throughout their treatment journey for all Partner Therapeutics medications (U.S. residents only). This comprehensive program provides assistance to ensure timely access and a positive treatment experience. PTxAssist site coordinators are available Monday to Friday 9:00 am – 5:00 pm ET at 1-877-353-8546 or you may visit https://www.ptxassist.com.

Global Managed Access Program

The PTx Global Managed Access Program is aimed at providing access to our approved treatments for patients living in regions where the medicines are not yet widely available. Through Tanner Pharma Group’s Global Access Program, patients may access PTx products utilizing the international Named Patient Program. For more information, you may contact PTxproducts@tannerpharma.com

Expanded Access to Bizengri and Leukine

Partner Therapeutics does not provide expanded access to zenocutuzumab or sargramostim. Patient access related inquiries should be sent to PTx Assist.